Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04821297 · ClinicalTrials.gov registry record · NA
Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results
A NA study of Cervical Carcinoma, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04821297 is a NA study of Cervical Carcinoma that has completed, run by Thomas Jefferson University. The registered enrollment target is 30 participants, below the 534-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04821297, a NA study of Cervical Carcinoma, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Interview
- OTHER Health Promotion and Education
Study Locations (1)
Pennsylvania
- Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2021-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04821297
The ClinicalTrials.gov registry entry for NCT04821297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 534-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (94% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT04821297 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04821297 about?
NCT04821297 is a clinical study titled "Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results". This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.
What is the current status of trial NCT04821297?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-02-18. Estimated completion is 2021-09-10.
What conditions does trial NCT04821297 study?
This clinical trial studies the following conditions: Cervical Carcinoma.
What interventions are being tested in trial NCT04821297?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Health Promotion and Education (OTHER).
Who is sponsoring clinical trial NCT04821297?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04821297 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
The Ohio State University (OSU) SCREEN Community Program
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
ACTIVE NOT RECRUITING · NA
-
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.